Bank of America
OCRX

Bank of America’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Bank of America’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-495
Closed -$1K – 7565
2016
Q3 		$1K Buy
495
+358
+261% +$894 ﹤0.01% 7037
2016
Q2 		$0 Buy
+137
New +$360 ﹤0.01% 7600
2015
Q3 		– Sell
-131
Closed – – 7599
2015
Q2 		$0 Buy
+131
New +$502 ﹤0.01% 7560
2014
Q4 		– Sell
-7,500
Closed -$37K – 8176
2014
Q3 		$37K Buy
7,500
+2,800
+60% +$16.2K ﹤0.01% 6711
2014
Q2 		$36K Sell
4,700
-300
-6% -$2.39K ﹤0.01% 6872
2014
Q1 		$53K Buy
5,000
+4,960
+12,400% +$70.9K ﹤0.01% 6390
2013
Q4 		$1K Buy
+40
New +$374 ﹤0.01% 7778
2013
Q3 		– Sell
-50
Closed – – 8154
2013
Q2 		$0 Buy
+50
New +$311 ﹤0.01% 7833

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Bank of America's OCRX Position: Q4 2016 in Review

Bank of America sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2016, closing a stake of 495 shares — an estimated $1K sold.

Bank of America first reported a position in OCRX in Q2 2013 and held it in 8 quarters. The position peaked at $53K in Q1 2014. 36 funds tracked by Wall St. Rank hold OCRX as of Q4 2016.

  • Bank of America reported no remaining Ocera Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Bank of America sold 495 Ocera Therapeutics, Inc. shares in Q4 2016, an estimated $1K.
  • Bank of America first reported a position in Ocera Therapeutics, Inc. in Q2 2013 and held it in 8 quarters.
  • Bank of America's Ocera Therapeutics, Inc. position peaked at $53K in Q1 2014.
  • 36 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.